Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen ...

DeepSeek is a stark reminder about the importance of strategic durability, and not just growth or growth potential, to a ...

A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...

Tempus AI's fourth-quarter results missed estimates as its costs increased. The medical technology firm's non-GAAP operating ...

Cathie Wood and Ark Invest seized the opportunity on Tuesday to buy the dip on Tempus AI ( NASDAQ: TEM) as the stock took a ...

Piper Sandler analyst David Westenberg maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research Report) today and set a price target ...

Cathie Wood‘s Ark Invest executed significant trades involving Airbnb Inc. (NASDAQ:ABNB), Coinbase Global Inc. (NASDAQ:COIN), ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...

We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...

We recently published a list of 10 AI Stocks on Analysts’ Radar As AI Spending Grows. In this article, we are going to take a ...

Tempus AI (NASDAQ:TEM – Get Free Report) was downgraded by stock analysts at JPMorgan Chase & Co. from an “overweight” rating ...

Tempus AI held its IPO in June 2024 and is applying AI solutions to healthcare. Investors should watch several metrics to assess the company's growth prospects. While Tempus AI could reap big ...